Table of Contents
Table 5-55: Morgan
Table 5-57: Noble
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 33 | 477.6 | 192 | 563.9 | 21 | 311.5 | 99 | 313.9 |
| Esophagus | * | # | 2 | # | * | # | 4 | # |
| Stomach | * | # | 4 | # | * | # | 1 | # |
| Colon excluding Rectum | * | # | 19 | 57.8** | * | # | 10 | 31.2** |
| Rectum and Rectosigmoid Junction | * | # | 8 | 23.4** | * | # | 2 | # |
| Liver | * | # | 1 | # | * | # | 1 | # |
| Pancreas | * | # | 3 | # | * | # | 4 | # |
| Lung and Bronchus | 5 | 86.5** | 39 | 118.8 | 7 | 115.6** | 39 | 120.9 |
| Melanoma of the Skin | * | # | 7 | 18.0** | * | # | 3 | # |
| Prostate | 9 | 135.4** | 48 | 144.2 | * | # | 7 | 26.8** |
| Urinary Bladder | * | # | 10 | 27.3** | * | # | 3 | # |
| Kidney and Renal Pelvis | * | # | 5 | 12.9** | * | # | 3 | # |
| Brain and Other Nervous System | * | # | 2 | # | * | # | 0 | # |
| Non-Hodgkin Lymphoma | * | # | 8 | 20.6** | * | # | 2 | # |
| Myeloma | * | # | 1 | # | * | # | 0 | # |
| Leukemia | * | # | 7 | 20.1** | * | # | 4 | # |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 40 | 475.4 | 172 | 420.0 | 18 | 211.0** | 83 | 194.4 |
| Colon excluding Rectum | * | # | 10 | 21.6** | * | # | 8 | 15.5** |
| Rectum and Rectosigmoid Junction | * | # | 12 | 27.1** | * | # | 2 | # |
| Liver | * | # | 1 | # | * | # | 2 | # |
| Pancreas | * | # | 2 | # | * | # | 7 | 16.6** |
| Lung and Bronchus | 6 | 64.8** | 33 | 79.1 | 6 | 67.9** | 23 | 55.2 |
| Melanoma of the Skin | * | # | 2 | # | * | # | 0 | # |
| Breast | 12 | 146.7** | 40 | 98.3 | 6 | 72.7** | 8 | 18.3** |
| Cervix Uteri | * | # | 3 | # | * | # | 1 | # |
| Corpus Uteri | * | # | 11 | 26.6** | * | # | 0 | # |
| Ovary | * | # | 8 | 20.6** | * | # | 6 | 14.5** |
| Urinary Bladder | * | # | 9 | 21.5** | * | # | 1 | # |
| Kidney and Renal Pelvis | * | # | 5 | 12.2** | * | # | 3 | # |
| Brain and Other Nervous System | * | # | 3 | # | * | # | 3 | # |
| Non-Hodgkin Lymphoma | * | # | 8 | 20.3** | * | # | 6 | 16.1** |
| Myeloma | * | # | 3 | # | * | # | 2 | # |
| Leukemia | * | # | 6 | 15.5** | * | # | 2 | # |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2006
Table of Contents
Table 5-55: Morgan
Table 5-57: Noble
